(1)
Wollenberg, A.; Cork, M.; Flohr, C.; Bewley, A.; Blauvelt, A.; Hong, C.- ho; Imafuku, S.; Schuttelaar, M. L.; Simpson, E.; Soong, W.; Amoudruz, P.; Wendicke Lophaven, K. .; Kurbasic, A.; Soldbro, L.; Strange Vest, N. .; Paller, A. Safety of Tralokinumab in Pediatric Patients Aged 12-17 Years With Moderate to Severe Atopic Dermatitis: Results from the Phase 3 ECZTRA 6 Trial. J of Skin 2023, 7, s140.